8VC, established in 1969 and headquartered in San Francisco, is a venture capital firm that invests in early-stage companies across various sectors, with a focus on enabling industry transformation. The firm, which is a Registered Investment Adviser, partners with founders to develop transformational technologies, targeting sectors such as healthcare, logistics, biology, IT infrastructure, and government & defense. 8VC aims to create long-term economic and societal value through its investments, promoting innovation and global prosperity.
Cognition AI is an applied AI lab focused on building end-to-end software agents that act as collaborative AI teammates. Their aim is to support engineering teams in being more efficient and innovative in their projects.
Patlytics
Series A in 2025
Patlytics is a developer of an artificial intelligence-powered platform that streamlines the entire patent lifecycle. The platform provides a range of features, including patent drafting, prosecution, litigation readiness, competitive landscape analysis, and real-time alerts and reports. By leveraging advanced technology, Patlytics enhances patent workflow efficiency, helping businesses to effectively manage their intellectual property portfolios and maintain a competitive edge in the market.
Latent Labs
Series A in 2025
Latent Labs is a pioneering AI laboratory specializing in programmable biology. The company develops advanced generative AI models that capture the fundamental principles of biology, empowering healthcare partners to create novel antibodies, optimize existing enzymes, and advance genetic engineering. This enables partners to gain unparalleled control over molecular biology, driving transformative advancements in health and sustainability.
Coram AI
Series A in 2025
Coram AI develops video intelligence systems aimed at enhancing business operations. The company offers a platform that transforms standard cameras into intelligent systems, providing valuable insights into various aspects of daily operations, including safety and security. By leveraging this technology, businesses of all sizes can gain fresh perspectives on their processes and make informed decisions that drive operational improvements. Coram AI's innovative approach allows clients to utilize their existing camera infrastructure more effectively, turning passive video recording into an active tool for operational enhancement.
Overland AI
Series A in 2025
Overland AI specializes in the development of autonomous navigation technology tailored for off-road vehicles. The company focuses on creating artificial intelligence-based solutions that enhance off-road autonomy, particularly for mission-critical sectors such as defense and national security. By utilizing machine learning and robotic systems, Overland AI provides modular software designed to facilitate the autonomous navigation of unimproved roads and rugged terrain. This technology enables clients to operate vehicles independently in challenging environments like mines, construction sites, and disaster zones, addressing the need for reliable transportation solutions in demanding conditions.
Wispr Flow
Venture Round in 2024
Wispr Flow is a developer of a personal computing platform aimed at an artificial intelligence-first future, emphasizing neural interfaces. The company focuses on a human-centered approach that integrates advancements in neurotechnology, machine learning, and hardware systems. By doing so, Wispr Flow seeks to make cutting-edge technology accessible to a wider audience, allowing users to engage with technology in a more intuitive and natural manner.
Candid Health
Series B in 2024
Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.
Tezi
Seed Round in 2024
Tezi is a technology company that specializes in autonomous AI-driven recruitment software. It is designed to streamline the entire hiring process by proactively sourcing candidates, screening applications, scheduling interviews, and collecting feedback, all while being trained by top hiring managers and recruiters. This enables businesses to hire more efficiently, quickly, and cost-effectively.
Pantheon AI
Seed Round in 2024
Pantheon AI is a technology company currently operating in stealth mode. While specific details about its products or services are not publicly available, the company is focused on developing innovative solutions within the artificial intelligence sector. Operating in stealth mode suggests that Pantheon AI is in the early stages of research and development, likely working on advanced AI technologies or applications that have not yet been disclosed to the market.
Patlytics
Seed Round in 2024
Patlytics is a developer of an artificial intelligence-powered platform that streamlines the entire patent lifecycle. The platform provides a range of features, including patent drafting, prosecution, litigation readiness, competitive landscape analysis, and real-time alerts and reports. By leveraging advanced technology, Patlytics enhances patent workflow efficiency, helping businesses to effectively manage their intellectual property portfolios and maintain a competitive edge in the market.
Unlearn.AI
Series C in 2024
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
Lightbeam.ai
Series A in 2024
LightBeam.ai is a leader in data security and privacy automation, dedicated to helping organizations manage and access sensitive information securely. The company offers a platform that utilizes advanced data management, entity linkage techniques, and deep learning to analyze documents, speech, and natural language processing at scale. This technology integrates seamlessly with various data sources across industries, enabling clients to derive actionable insights while maintaining data privacy and confidentiality. By providing a unified control tower for data cataloging, access, and sharing, LightBeam empowers privacy and compliance executives to ensure continuous compliance, while information security professionals can trust that sensitive data is accessed and utilized securely.
Latent Labs
Seed Round in 2024
Latent Labs is a pioneering AI laboratory specializing in programmable biology. The company develops advanced generative AI models that capture the fundamental principles of biology, empowering healthcare partners to create novel antibodies, optimize existing enzymes, and advance genetic engineering. This enables partners to gain unparalleled control over molecular biology, driving transformative advancements in health and sustainability.
Coram AI
Seed Round in 2023
Coram AI develops video intelligence systems aimed at enhancing business operations. The company offers a platform that transforms standard cameras into intelligent systems, providing valuable insights into various aspects of daily operations, including safety and security. By leveraging this technology, businesses of all sizes can gain fresh perspectives on their processes and make informed decisions that drive operational improvements. Coram AI's innovative approach allows clients to utilize their existing camera infrastructure more effectively, turning passive video recording into an active tool for operational enhancement.
SapientAI
Seed Round in 2023
SapientAI created AI Test Coder, the first platform that combines contextual insights, coding intelligence, and generative AI to generate correct test code for software developers.
DevEfficiency
Seed Round in 2023
DevEfficiency has developed AI Test Coder, a groundbreaking platform that integrates contextual insights and coding intelligence to produce accurate test code.
NeuralScripter
Seed Round in 2023
By harnessing contextual insights, code intelligence, and generative AI, NeuralScripter achieves complete automation of the entire software testing spectrum.
DevAccuracy
Seed Round in 2023
DevAccuracy's AI Test Coder is a groundbreaking platform that harnesses contextual insights and intelligent coding to automate the generation of precise test code. This innovative solution streamlines the testing process by ensuring accuracy and efficiency, setting a new standard in software development. DevAccuracy is committed to revolutionizing the industry through advanced AI-driven technologies tailored to enhance code quality and predict potential issues.
Tome
Series B in 2023
Tome is a company that transforms the sales process for teams by utilizing custom language models to enhance productivity at every stage of sales. The platform aids sales representatives in building qualified pipelines through detailed account research, value hypotheses, and automated outreach. It accelerates existing sales efforts by providing automated call summaries, updated account plans, CRM synchronization, and auto-generated marketing collateral. Additionally, Tome offers insights that help optimize sales strategies, enabling teams to identify effective messaging and features that lead to quicker, larger deals. By streamlining repetitive tasks, Tome allows account executives to focus more on customer interactions, while sales leaders benefit from improved pipeline quality and deal closure rates. Revenue operations leaders can trust that their systems are functioning efficiently, maximizing the potential of their sales processes.
Spartan Radar
Series B in 2023
Spartan Radar specializes in advanced radar technology that creates high-resolution real-time imagery, utilizing proprietary software algorithms that incorporate machine learning and edge-processing. By mimicking human sensory perception, Spartan's solutions enhance the performance of existing advanced driver-assistance systems (ADAS) by improving resolution, response time, and range while maintaining low computational demands. The company's expertise in signal processing, developed through years of experience in the aerospace and automotive sectors, enables it to offer cost-effective sensing solutions. Spartan's platform is applicable across various industries, including drone and automotive applications, positioning the company as a leader in innovative radar technology.
Atomic AI
Series A in 2023
Atomic AI is focused on advancing RNA drug discovery through the integration of machine learning and structural biology. The company operates a content intelligence platform that facilitates the rational design of new molecules and medicines. By leveraging engagement data from clients' analytics, Atomic AI gathers insights to create predictive reports on various topics, including optimal publishing times and distribution channels. This approach equips users with innovative strategies to develop treatments or cures for diseases by specifically targeting RNA structures.
QuantumCheck AI
Seed Round in 2023
By harnessing contextual insights, code intelligence, and generative AI, QuantumCheck AI achieves complete automation of the entire software testing spectrum.
Wispr Flow
Seed Round in 2022
Wispr Flow is a developer of a personal computing platform aimed at an artificial intelligence-first future, emphasizing neural interfaces. The company focuses on a human-centered approach that integrates advancements in neurotechnology, machine learning, and hardware systems. By doing so, Wispr Flow seeks to make cutting-edge technology accessible to a wider audience, allowing users to engage with technology in a more intuitive and natural manner.
Rephrase.ai
Series A in 2022
Rephrase.ai specializes in an AI-powered video creation technology that transforms text into animated videos featuring realistic facial representations of individuals. This innovative approach employs generative AI to analyze and learn the facial features of specific people in relation to spoken audio, allowing the system to create photorealistic visuals for any new text or audio input. The platform serves a variety of applications, enabling clients to produce training videos, personalize sales presentations, animate characters in augmented and virtual reality, and provide a visual identity for digital assistants. Through its advanced technology, Rephrase.ai enhances the way organizations communicate and engage with their audiences.
Digital Diagnostics
Series B in 2022
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing healthcare through technology. Founded in 2010 by Michael Abramoff, MD, PhD, the company has developed a suite of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR, which identifies diabetic retinopathy; IDx-G, which monitors glaucoma indicators; and IDx-AMD, designed to detect age-related macular degeneration. The company also offers algorithms for diagnosing conditions such as Alzheimer's disease, cardiovascular disease, and stroke risk. By providing these innovative solutions, Digital Diagnostics aims to improve the quality, accessibility, equity, and affordability of healthcare worldwide. Operating from Coralville, Iowa, the company distributes its products both domestically and internationally, striving to integrate autonomous AI into standard clinical practices and enhance patient outcomes.
BigHat Biosciences
Series B in 2022
BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.
Unlearn.AI
Series B in 2022
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
Candid Health
Series A in 2022
Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.
Ponder
Seed Round in 2022
Ponder Data Inc. specializes in providing enterprise-ready tools that facilitate rapid and flexible experimentation with data at scale. The company's platform is designed to enhance productivity for data teams by enabling them to obtain insights more swiftly, utilizing familiar tools. Ponder's technology focuses on maintaining scalable machine learning and analytics capabilities, allowing users to handle workloads of varying sizes while preserving the user-friendly nature of the pandas API. This approach empowers organizations to perform data science tasks efficiently and effectively, making it easier for teams to derive valuable insights from their data.
Metaphysic
Seed Round in 2022
Metaphysic is a developer of software focused on the creation of synthetic media, aiming to enhance human expression through ethical applications. The company's technology reconstructs low-resolution video footage and generates realistic facial representations, allowing users to edit expressions and facial features seamlessly. This innovative approach enables content creators to produce immersive and realistic experiences in various media, particularly within the metaverse. By leveraging artificial intelligence, Metaphysic provides tools that expand the creative possibilities for artists and filmmakers, ensuring a natural and engaging interaction with digital content.
IntelliCodeCraft
Seed Round in 2022
IntelliCodeCraft uses AI to test code with intelligence based algorithms. By harnessing contextual insights, code intelligence, and generative AI, IntelliCodeCraft achieves complete automation of the entire software testing spectrum.
Wispr Flow
Seed Round in 2021
Wispr Flow is a developer of a personal computing platform aimed at an artificial intelligence-first future, emphasizing neural interfaces. The company focuses on a human-centered approach that integrates advancements in neurotechnology, machine learning, and hardware systems. By doing so, Wispr Flow seeks to make cutting-edge technology accessible to a wider audience, allowing users to engage with technology in a more intuitive and natural manner.
Deliverr
Series E in 2021
Deliverr, Inc. is a San Francisco-based company founded in 2017 that specializes in order fulfillment services for e-commerce retailers. The company provides shipping solutions designed to help online businesses meet shipping standards and avoid penalties associated with late shipments. By leveraging machine learning and predictive intelligence, Deliverr's platform enables sellers to offer various shipping options and access services such as warehousing, order handling, and packaging. This tech-enabled approach allows sellers of all sizes to fulfill orders efficiently, improve customer satisfaction, and expand their market reach through fast and cost-effective fulfillment solutions.
Spartan Radar
Series A in 2021
Spartan Radar specializes in advanced radar technology that creates high-resolution real-time imagery, utilizing proprietary software algorithms that incorporate machine learning and edge-processing. By mimicking human sensory perception, Spartan's solutions enhance the performance of existing advanced driver-assistance systems (ADAS) by improving resolution, response time, and range while maintaining low computational demands. The company's expertise in signal processing, developed through years of experience in the aerospace and automotive sectors, enables it to offer cost-effective sensing solutions. Spartan's platform is applicable across various industries, including drone and automotive applications, positioning the company as a leader in innovative radar technology.
Immunai
Series B in 2021
Immunai Inc. is a biotechnology company that specializes in developing an artificial intelligence-based immune profiling platform aimed at enhancing drug development and improving disease detection, diagnosis, and treatment. The company utilizes single-cell genomics and machine learning algorithms to conduct high-resolution profiling of the immune system, generating valuable biological insights that facilitate research and development. Immunai's platform focuses on biomarker discovery, enabling the identification of how immune cells respond to various conditions, and supports the development of therapies for oncology and autoimmune disorders. Established in 2018 and headquartered in New York City, Immunai also maintains offices in San Francisco and Tel Aviv, collaborating with academic institutions, biopharmaceutical firms, and biotechnology companies to advance its mission of mapping the immune system and its functions.
Spartan Radar
Seed Round in 2021
Spartan Radar specializes in advanced radar technology that creates high-resolution real-time imagery, utilizing proprietary software algorithms that incorporate machine learning and edge-processing. By mimicking human sensory perception, Spartan's solutions enhance the performance of existing advanced driver-assistance systems (ADAS) by improving resolution, response time, and range while maintaining low computational demands. The company's expertise in signal processing, developed through years of experience in the aerospace and automotive sectors, enables it to offer cost-effective sensing solutions. Spartan's platform is applicable across various industries, including drone and automotive applications, positioning the company as a leader in innovative radar technology.
Claritype
Pre Seed Round in 2021
Claritype is a company that provides an AI-enabled semantic layer for data lakes, focusing on automating data integration. Its data platform features an AI modeling engine that creates an interconnected network of business data, significantly reducing the time required for data preparation from weeks to hours. This efficiency allows teams to dedicate more time to analysis and deriving insights, ultimately enhancing the quality of data, facilitating project progress, and accelerating future insights. Claritype's solutions aim to improve the underlying data infrastructure, empowering data teams to work more effectively and make informed decisions.
Pave
Seed Round in 2021
Pave helps consumer and SMB credit risk teams increase approvals through AI-powered cashflow analytics. 100 million+ US consumers and businesses are financially underserved, simply because their data is not recognized by the traditional financial system. We solve this by transforming transaction data, loan performance outcomes, and credit reports into Cashflow-driven Attributes and Scores, enabling increased financial access to new customer segments without increasing risk. Our mission is to build a future where every person and business has access to equitable credit solutions by creating a new standard of Cashflow-driven Analytics.
Unstruk Data
Seed Round in 2021
Unstruk Data was started on the premise that expert domain knowledge is being lost at an alarming rate, as employees leave and projects end. For companies that manage and track real-world assets, as the volume of their acquired spatial and unstructured data rises, the amount of hidden or "dark" data increases even more rapidly. Unstruk offers a full-stack knowledge platform which leverages no-code machine learning and a user-friendly spatial data analytics interface. With the Unstruk Data Portal, geo-enabled businesses can catalog, correlate and search their video, audio, 3D point clouds, shape files, orthographic images, PDFs, emails (and more) - to make data-driven decisions more easily and without coding required. Data can be further enriched and correlated via external integrations with ESRI ArcGIS, satellite imagery providers, databases and other API-based services.
Deliverr
Convertible Note in 2021
Deliverr, Inc. is a San Francisco-based company founded in 2017 that specializes in order fulfillment services for e-commerce retailers. The company provides shipping solutions designed to help online businesses meet shipping standards and avoid penalties associated with late shipments. By leveraging machine learning and predictive intelligence, Deliverr's platform enables sellers to offer various shipping options and access services such as warehousing, order handling, and packaging. This tech-enabled approach allows sellers of all sizes to fulfill orders efficiently, improve customer satisfaction, and expand their market reach through fast and cost-effective fulfillment solutions.
Deliverr
Series D in 2021
Deliverr, Inc. is a San Francisco-based company founded in 2017 that specializes in order fulfillment services for e-commerce retailers. The company provides shipping solutions designed to help online businesses meet shipping standards and avoid penalties associated with late shipments. By leveraging machine learning and predictive intelligence, Deliverr's platform enables sellers to offer various shipping options and access services such as warehousing, order handling, and packaging. This tech-enabled approach allows sellers of all sizes to fulfill orders efficiently, improve customer satisfaction, and expand their market reach through fast and cost-effective fulfillment solutions.
BigHat Biosciences
Series A in 2021
BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.
Flywheel.io
Series B in 2021
Flywheel is a data management and analysis platform built specifically for scientists and the researcher's workflow. They empower research momentum by focusing on data and medical image capture, content management, scientific computation, and collaboration. With reproducible research in mind, they combine open-source methods from top universities, a modern web user interface, and an extensible compute engine based on containerization technology. The result is a software platform to accelerate discovery and help researchers do science, not IT. Flywheel accelerates new scientific discoveries in life-science, biotech, and academic imaging research through cloud-scale collaboration. As a result, imaging researchers are able to avoid innovation bottlenecks, and accelerate discovery by doing more science, and less IT.
Model Medicines
Pre Seed Round in 2021
Model Medicines is a company focused on accelerating drug development through the integration of human expertise and artificial intelligence. Utilizing its ActivPred AI Drug Discovery Platform, Model Medicines applies machine learning to model chemistry and human biology, which facilitates the discovery of therapeutics that can be repositioned for treating complex diseases. The company has developed a robust pipeline of patent-pending therapeutics targeting various medical conditions, including oncology, infectious diseases, neurological disorders, and gastric disorders. By leveraging drug development data alongside advanced AI techniques, Model Medicines aims to expedite the clinical trial process, allowing new drugs to enter trials within a matter of months, thereby enhancing the efficiency and effectiveness of drug development for healthcare institutions.
Atomic AI
Seed Round in 2021
Atomic AI is focused on advancing RNA drug discovery through the integration of machine learning and structural biology. The company operates a content intelligence platform that facilitates the rational design of new molecules and medicines. By leveraging engagement data from clients' analytics, Atomic AI gathers insights to create predictive reports on various topics, including optimal publishing times and distribution channels. This approach equips users with innovative strategies to develop treatments or cures for diseases by specifically targeting RNA structures.
Lightbeam.ai
Seed Round in 2020
LightBeam.ai is a leader in data security and privacy automation, dedicated to helping organizations manage and access sensitive information securely. The company offers a platform that utilizes advanced data management, entity linkage techniques, and deep learning to analyze documents, speech, and natural language processing at scale. This technology integrates seamlessly with various data sources across industries, enabling clients to derive actionable insights while maintaining data privacy and confidentiality. By providing a unified control tower for data cataloging, access, and sharing, LightBeam empowers privacy and compliance executives to ensure continuous compliance, while information security professionals can trust that sensitive data is accessed and utilized securely.
Unlearn.AI
Series A in 2020
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
Candid Health
Seed Round in 2020
Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.
Deliverr
Series C in 2020
Deliverr, Inc. is a San Francisco-based company founded in 2017 that specializes in order fulfillment services for e-commerce retailers. The company provides shipping solutions designed to help online businesses meet shipping standards and avoid penalties associated with late shipments. By leveraging machine learning and predictive intelligence, Deliverr's platform enables sellers to offer various shipping options and access services such as warehousing, order handling, and packaging. This tech-enabled approach allows sellers of all sizes to fulfill orders efficiently, improve customer satisfaction, and expand their market reach through fast and cost-effective fulfillment solutions.
BigHat Biosciences
Seed Round in 2019
BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.
IdeaFlow
Venture Round in 2019
IdeaFlow, Inc. is a technology company based in Palo Alto, California, founded in 2015. It has developed a human-artificial intelligence hybrid platform aimed at enhancing collaboration among teams of analysts. This platform enables users to create, visualize, and analyze complex networks of information by integrating data from various sources, which may have been previously underutilized. By combining human insight with machine processing capabilities, IdeaFlow allows teams to uncover connections and insights that might be overlooked by automated systems alone. The company's innovative approach represents an extension of human cognitive abilities into the digital realm, facilitating more effective data-driven decision-making within organizations.
Deliverr
Series B in 2019
Deliverr, Inc. is a San Francisco-based company founded in 2017 that specializes in order fulfillment services for e-commerce retailers. The company provides shipping solutions designed to help online businesses meet shipping standards and avoid penalties associated with late shipments. By leveraging machine learning and predictive intelligence, Deliverr's platform enables sellers to offer various shipping options and access services such as warehousing, order handling, and packaging. This tech-enabled approach allows sellers of all sizes to fulfill orders efficiently, improve customer satisfaction, and expand their market reach through fast and cost-effective fulfillment solutions.
Levee
Seed Round in 2019
Levee is a technology company based in São Paulo, Brazil, founded in 2016. It has developed a platform that leverages artificial intelligence and machine learning to connect informal, unskilled workers with formal job opportunities that offer greater security and higher pay. The company's solutions cater to C-Level executives and human resources professionals across various sectors, including retail, food services, and healthcare. Levee's approach combines data science, automation, and recruitment marketing to streamline the hiring process for frontline workers. By enhancing efficiency and productivity, Levee aims to reduce absenteeism and improve overall employee engagement and turnover rates, enabling businesses to build a more effective workforce.
People Data Labs
Series A in 2018
People Data Labs specializes in providing high-quality B2B data for developers, engineers, and data scientists. With a robust database of 3 billion accurate records, the company enables clients to create and enhance person profiles, enrich existing data, and support predictive modeling and artificial intelligence applications. Their platform serves various sectors, including sales and marketing, investment research, fraud detection, and talent acquisition, ensuring that clients can build and scale innovative, data-driven products effectively. By acting as a reliable data partner, People Data Labs supports both enterprise and startup clients in achieving greater efficiency and success in their data-enabled initiatives.
Deliverr
Series A in 2018
Deliverr, Inc. is a San Francisco-based company founded in 2017 that specializes in order fulfillment services for e-commerce retailers. The company provides shipping solutions designed to help online businesses meet shipping standards and avoid penalties associated with late shipments. By leveraging machine learning and predictive intelligence, Deliverr's platform enables sellers to offer various shipping options and access services such as warehousing, order handling, and packaging. This tech-enabled approach allows sellers of all sizes to fulfill orders efficiently, improve customer satisfaction, and expand their market reach through fast and cost-effective fulfillment solutions.
Digital Diagnostics
Series A in 2018
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing healthcare through technology. Founded in 2010 by Michael Abramoff, MD, PhD, the company has developed a suite of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR, which identifies diabetic retinopathy; IDx-G, which monitors glaucoma indicators; and IDx-AMD, designed to detect age-related macular degeneration. The company also offers algorithms for diagnosing conditions such as Alzheimer's disease, cardiovascular disease, and stroke risk. By providing these innovative solutions, Digital Diagnostics aims to improve the quality, accessibility, equity, and affordability of healthcare worldwide. Operating from Coralville, Iowa, the company distributes its products both domestically and internationally, striving to integrate autonomous AI into standard clinical practices and enhance patient outcomes.
Hive
Series B in 2018
Hive is a San Francisco-based company that specializes in cloud-based artificial intelligence solutions aimed at enhancing business processes through deep learning and computer vision. It offers a range of products, including Hive Media, an analytics platform for broadcasters and advertisers; Hive Security, which provides video analytics and visual intelligence software; Hive Auto, focusing on visual perception for autonomous vehicles; and Hive Retail, which delivers custom deep learning solutions for retail operations. With a significant portfolio of pre-trained AI models, Hive supports billions of API requests monthly and addresses critical business needs such as content moderation, brand protection, and ad targeting. The company has raised substantial capital from prominent investors and employs over 175 full-time staff, complemented by a global network of contributors for data labeling operations. Hive was incorporated in 2013 and has established itself as a leader in AI technology for diverse enterprise applications.
Alloy.ai
Series A in 2018
Alloy.ai is a demand and inventory control platform designed to assist consumer goods brands in optimizing their supply chain operations. By providing daily insights at the SKU-store level, Alloy.ai enables brands to swiftly identify and address issues, enhancing their responsiveness to market changes. The platform integrates over 850 pre-built connectors that combine point-of-sale and inventory data with supply chain information, offering comprehensive visibility across networks. This capability allows brands to predict challenges that competitors may overlook. Trusted by a range of companies, from Fortune 500 firms to emerging digital brands, Alloy.ai helps clients achieve significant improvements, including over 35% reductions in out-of-stock situations and notable increases in their bottom line.
LocateAI
Venture Round in 2018
LocateAI Inc. develops artificial intelligence-powered software solutions specifically for the retail industry, focusing on optimizing the location selection process for new retail and restaurant establishments. Founded by Stanford computer scientists in 2014 and based in San Francisco, the company leverages geospatial data and machine learning to enhance decision-making in real estate transactions, a sector valued at approximately $4 trillion. Their predictive analytical platform provides unique insights, enabling retailers, restaurants, developers, real estate brokers, investors, and city planners to make informed choices backed by millions of data points. Core technologies employed by LocateAI include data mining, machine learning, and data visualization, facilitating smarter and faster transactions within the industry.
MindBridge
Series A in 2018
MindBridge Analytics Inc. is a Canadian FinTech company specializing in financial analytics software. The company leverages machine learning and artificial intelligence to identify anomalous patterns in financial activities, uncovering both unintentional errors and intentional misstatements. Its flagship product, the MindBridge AI Auditor, is designed for audit, assurance, and commercial enterprises, enabling organizations to analyze financial datasets effectively. By providing risk-weighted analysis and deep insights into monetary flows, MindBridge helps companies enhance their controls and improve decision-making processes, ultimately minimizing financial loss across various industries.
Forethought
Seed Round in 2018
Forethought, established in 2017 and based in Palo Alto, California, specializes in developing AI models for question-answering and information retrieval. The company's flagship product, Agatha Answers, is a smart agent that integrates into customer support teams' workflows, providing real-time assistance, automating repetitive tasks, and offering predictive insights to enhance efficiency and productivity.
PathAI
Series A in 2017
PathAI, Inc. is a technology company that specializes in developing artificial intelligence solutions for pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI focuses on enhancing the accuracy and efficiency of cancer diagnosis and treatment. The company's platform employs machine and deep learning techniques to analyze large datasets, assisting pathologists in making rapid and precise diagnoses for patients. By addressing complex challenges in pathology, PathAI aims to facilitate personalized medicine and improve patient outcomes by identifying individuals who may benefit from innovative therapies.
Knowde
Pre Seed Round in 2017
Knowde operates an online marketplace focused on the chemical industry, enhancing the accessibility of trading chemicals, polymers, and industrial ingredients. Its platform utilizes advanced technologies, including deep learning and self-learning data models, to facilitate the search, filtering, sampling, quoting, and purchasing of products tailored to client specifications. By offering a comprehensive chemical taxonomy, Knowde empowers global chemical producers and distributors to transform their operations digitally. This innovative approach allows clients to compare and access products from suppliers worldwide, streamlining the procurement process in the chemical sector. The company has garnered support from prominent investors, highlighting its potential in revolutionizing how chemical transactions are conducted.
MindBridge
Seed Round in 2017
MindBridge Analytics Inc. is a Canadian FinTech company specializing in financial analytics software. The company leverages machine learning and artificial intelligence to identify anomalous patterns in financial activities, uncovering both unintentional errors and intentional misstatements. Its flagship product, the MindBridge AI Auditor, is designed for audit, assurance, and commercial enterprises, enabling organizations to analyze financial datasets effectively. By providing risk-weighted analysis and deep insights into monetary flows, MindBridge helps companies enhance their controls and improve decision-making processes, ultimately minimizing financial loss across various industries.
People Data Labs
Series A in 2017
People Data Labs specializes in providing high-quality B2B data for developers, engineers, and data scientists. With a robust database of 3 billion accurate records, the company enables clients to create and enhance person profiles, enrich existing data, and support predictive modeling and artificial intelligence applications. Their platform serves various sectors, including sales and marketing, investment research, fraud detection, and talent acquisition, ensuring that clients can build and scale innovative, data-driven products effectively. By acting as a reliable data partner, People Data Labs supports both enterprise and startup clients in achieving greater efficiency and success in their data-enabled initiatives.
Hive
Series A in 2016
Hive is a San Francisco-based company that specializes in cloud-based artificial intelligence solutions aimed at enhancing business processes through deep learning and computer vision. It offers a range of products, including Hive Media, an analytics platform for broadcasters and advertisers; Hive Security, which provides video analytics and visual intelligence software; Hive Auto, focusing on visual perception for autonomous vehicles; and Hive Retail, which delivers custom deep learning solutions for retail operations. With a significant portfolio of pre-trained AI models, Hive supports billions of API requests monthly and addresses critical business needs such as content moderation, brand protection, and ad targeting. The company has raised substantial capital from prominent investors and employs over 175 full-time staff, complemented by a global network of contributors for data labeling operations. Hive was incorporated in 2013 and has established itself as a leader in AI technology for diverse enterprise applications.
PathAI
Seed Round in 2016
PathAI, Inc. is a technology company that specializes in developing artificial intelligence solutions for pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI focuses on enhancing the accuracy and efficiency of cancer diagnosis and treatment. The company's platform employs machine and deep learning techniques to analyze large datasets, assisting pathologists in making rapid and precise diagnoses for patients. By addressing complex challenges in pathology, PathAI aims to facilitate personalized medicine and improve patient outcomes by identifying individuals who may benefit from innovative therapies.
Alloy.ai
Seed Round in 2016
Alloy.ai is a demand and inventory control platform designed to assist consumer goods brands in optimizing their supply chain operations. By providing daily insights at the SKU-store level, Alloy.ai enables brands to swiftly identify and address issues, enhancing their responsiveness to market changes. The platform integrates over 850 pre-built connectors that combine point-of-sale and inventory data with supply chain information, offering comprehensive visibility across networks. This capability allows brands to predict challenges that competitors may overlook. Trusted by a range of companies, from Fortune 500 firms to emerging digital brands, Alloy.ai helps clients achieve significant improvements, including over 35% reductions in out-of-stock situations and notable increases in their bottom line.
Crunchbase
Series A in 2015
Crunchbase is a comprehensive platform that assists over 80 million investors, analysts, and dealmakers in identifying and acting on private market opportunities through detailed analysis of company activities. It enables users to discover significant companies via its homepage, Crunchbase Scout, and search functionalities. The platform offers proprietary predictions and insights on organizational profiles, facilitating informed decision-making. Additionally, Crunchbase enhances team efficiency with various features such as data exports, administrative tools, and integrations. By providing unique private company intelligence, Crunchbase bridges the gap between data access and actionable business decisions, ultimately supporting users in navigating the complexities of the investment landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.